Cargando…

Exposure to excess insulin (glargine) induces type 2 diabetes mellitus in mice fed on a chow diet

We have previously shown that insulin plays an important role in the nutrient-induced insulin resistance. In this study, we tested the hypothesis that chronic exposure to excess long-acting insulin (glargine) can cause typical type 2 diabetes mellitus (T2DM) in normal mice fed on a chow diet. C57BL/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xuefeng, Mei, Shuang, Gu, Haihua, Guo, Huailan, Zha, Longying, Cai, Junwei, Li, Xuefeng, Liu, Zhenqi, Cao, Wenhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045231/ https://www.ncbi.nlm.nih.gov/pubmed/24741073 http://dx.doi.org/10.1530/JOE-14-0117

Ejemplares similares

A Small Amount of Dietary Carbohydrate Can Promote the HFD-Induced Insulin Resistance to a Maximal Level
por: Mei, Shuang, et al.
Publicado: (2014)

El chow chow
por: Milani, Isabella
Publicado: (1997)

El chow chow
por: Beauchamp, Richard
Publicado: (1998)

Soyasaponins Can Blunt Inflammation by Inhibiting the Reactive Oxygen Species-Mediated Activation of PI3K/Akt/NF-kB Pathway
por: Zha, Longying, et al.
Publicado: (2014)

Computational Analysis of Plasma Lipidomics from Mice Fed Standard Chow and Ketogenic Diet
por: Seufert, Amy L., et al.
Publicado: (2023)

The origin of chow chows in the light of the East Asian breeds
por: Yang, Hechuan, et al.
Publicado: (2017)

Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus
por: Linnebjerg, Helle, et al.
Publicado: (2016)

In Utero Exposure of Hyperlipidemic Mice to Diesel Exhaust: Lack of Effects on Atherosclerosis in Adult Offspring Fed a Regular Chow Diet
por: Harrigan, Jenna, et al.
Publicado: (2017)

Energy expenditure in chow-fed female non-human primates of various weights
por: Rising, Russell, et al.
Publicado: (2008)

Rats Eat a Cafeteria-Style Diet to Excess but Eat Smaller Amounts and Less Frequently when Tested with Chow
por: South, Timothy, et al.
Publicado: (2014)

Chow diet in mouse aging studies: nothing regular about it
por: Lee, Jennifer, et al.
Publicado: (2023)

Serum Amyloid A Stimulates Vascular and Renal Dysfunction in Apolipoprotein E-Deficient Mice Fed a Normal Chow Diet
por: Chami, Belal, et al.
Publicado: (2019)

Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus
por: Wang, Weimin, et al.
Publicado: (2022)

Reduced Atherosclerotic Lesion Size in P-Selectin Deficient Apolipoprotein E-Knockout Mice Fed a Chow but Not a Fat Diet
por: Bourdillon, Marie-Claude, et al.
Publicado: (2006)

Paraganglioma of the Tongue in a Chow Chow Dog: A Comparison With the Human Counterpart and Literature Review
por: Rodrigues, Fábio Ranyeri Nunes, et al.
Publicado: (2020)

Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus
por: Ilag, L. L., et al.
Publicado: (2016)

Systemic Insulin Resistance and Metabolic Perturbations in Chow Fed Inducible Nitric Oxide Synthase Knockout Male Mice: Partial Reversal by Nitrite Supplementation
por: Aggarwal, Hobby, et al.
Publicado: (2020)

Insulin glargine overdose
por: Doğan, Fatma Sarı, et al.
Publicado: (2012)

MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
por: Hoy, Sheridan M.
Publicado: (2020)

On torsion elements in the Chow-groups of quadrics
por: Vishik, A
Publicado: (2000)

Pemafibrate, a PPAR alpha agonist, attenuates neointima formation after vascular injury in mice fed normal chow and a high-fat diet
por: Horikawa, Tsuyoshi, et al.
Publicado: (2020)

A Neutralizing Antibody Targeting Oxidized Phospholipids Promotes Bone Anabolism in Chow‐Fed Young Adult Mice
por: Palmieri, Michela, et al.
Publicado: (2020)

Insulin glargine and the risk of cancer
por: Ahmed, FA
Publicado: (2010)

Twice-daily insulin glargine for patients with uncontrolled type 2 diabetes mellitus
por: Eledrisi, Mohsen, et al.
Publicado: (2018)

Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus
por: Hoy, Sheridan M.
Publicado: (2020)

The difference of chows affects mouse physiological conditions
por: WATANABE, Taiki, et al.
Publicado: (2022)

A world renowned psychophysiologist: Kaoliang Chow
por: Zhang, Lei, et al.
Publicado: (2020)

Effects of Switching from Insulin Glargine or Detemir to Insulin Degludec in Patients with Type 1 Diabetes Mellitus
por: Kusunoki, Yoshiki, et al.
Publicado: (2013)

A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
por: Candido, Riccardo, et al.
Publicado: (2018)

Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
por: Tarigan, Tri Juli Edi, et al.
Publicado: (2021)

Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus
por: Evans, Marc, et al.
Publicado: (2017)

Familles de cycle algébriques: schéma de Chow
por: Angéniol, Bernard
Publicado: (1981)

Correction to: A world renowned psychophysiologist: Kaoliang Chow
por: Zhang, Lei, et al.
Publicado: (2021)

Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
por: Steinstraesser, A, et al.
Publicado: (2014)

Ketogenic versus Western and standard chow diets favorably alters fat deposition and serum biomarkers in rats
por: Holland, Angelia M, et al.
Publicado: (2015)

Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
por: Liu, Dan, et al.
Publicado: (2021)

Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
por: Lau, Ip Tim, et al.
Publicado: (2017)

Inflammation-induced microvascular insulin resistance is an early event in diet-induced obesity
por: Zhao, Lina, et al.
Publicado: (2015)

A case of hypersensitivity to soluble and isophane insulins but not to insulin glargine
por: Belhekar, Mahesh N., et al.
Publicado: (2015)

Insulin glargine use and breast cancer risk: Associations with cumulative exposure
por: Peeters, Paul J. H. L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2q2frlsk35iddrbod6po3mqbvs